Showing results (191-200 of 239) with videos related to
Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumabSuzanne L Topalian, Mario Sznol, David F McDermott, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2023
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving NivolumabSuzanne L Topalian, Mario Sznol, David F McDermott, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2020
Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 TrialSuzanne L Topalian, Shailender Bhatia, Asim Amin, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 22, 2025
Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLCTetsuya Mitsudomi, John V Heymach, Martin Reck, et al.The New England Journal of Medicine|October 23, 2023
Perioperative Durvalumab for Resectable Non-Small-Cell Lung CancerJohn V Heymach, David Harpole, Tetsuya Mitsudomi, et al.Journal of Translational Medicine|September 7, 2020
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)Paolo A Ascierto, Igor Puzanov, Sanjiv S Agarwala, et al.The New England Journal of Medicine|June 2, 2025
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung CancerPatrick M Forde, Jonathan D Spicer, Mariano Provencio, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2025
Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: a joint SITC and INMC effortJ S Deutsch, R A Scolyer, E Burton, et al.Journal for Immunotherapy of Cancer|October 18, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0Anna C Pavlick, Charlotte E Ariyan, Elizabeth I Buchbinder, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2019
Intratumoral Adaptive Immunosuppression and Type 17 Immunity in Mismatch Repair Proficient Colorectal TumorsNicolas J Llosa, Brandon Luber, Ada J Tam, et al.Pageof 24